Managed Care

Cangrelor Versus Clopidogrel in Intraprocedural Stent Thrombosis (IPST): CHAMPION PHOENIX

Philippe Genereux, MD, of the Angiographic Core Laboratory, Cardiovascular Research Foundation in New York, NY, says that cangrelor was associated with significant reductions in the key endpoints of stent thrombosis and IPST when compared with clopidogrel.


Medical Devices Summit Boston, MA February 19–20, 2015
3rd Annual Summit to Improve Adherence and Enhance Patient Engagement Philadelphia, PA March 9–10, 2015
Value-Added Solutions for Enhanced Customer Experience Philadelphia, PA March 9, 2015